姓名：章淼滢 學(xué)曆學(xué)位：臨床博士 職稱：副主任醫師 專業：兒童内分泌

醫療專長(cháng)：
擅長(cháng)身材矮小、青少年青春發(fā)育異常、糖尿病、肥胖、甲狀腺、低血糖等内分泌疾病診治
個人簡曆：
優生優育協會(huì)兒童生長(cháng)與特殊食品學(xué)組委員，亞太兒科内分泌學(xué)會(huì)（APPES）、歐洲兒科内分泌學(xué)會(huì)（ESPE）、上海市醫師協會(huì)會(huì)員，從事(shì)兒童内分泌專業15餘年，曾赴韓國(guó)首爾國(guó)立大學(xué)兒童醫院和英國(guó)Great Ormond Street Hospital國(guó)際低血糖中心進(jìn)修學(xué)習。在國(guó)際SCI和國(guó)内權威及核心雜志發(fā)表數十篇兒童内分泌相關論文，主持國(guó)家自然科學(xué)基金項目，參與上海市科委基金科研項目。
研究方向(xiàng)：
兒童内分泌疾病
科研成(chéng)果及論著：
1)    章淼滢,倪錦文,葛璟潔,管一晖,裴舟,孫成(chéng)君,吳靜,徐真然,楊琳,羅飛宏,程若倩.(18)F
2)    -DOPA-PET CT顯像輔助診斷高胰島素血症性低血糖患兒臨床特點, 中華兒科雜志, 2021, 59(10): 853-858
3)    Zhang Miaoying, Sun Chengjun, Liu Renchao, Dong Chenbing, Cheng Ruoqian, Zheng Zhangqian, Wu Bingbing, Luo Feihong, Pei Zhou, Lu Wei. Phenotypes and epigenetic errors in patients with Be ckwith-Wiedemann syndrome in China, Translational Pediatrics, 2020, 9(5): 653
4)    Xu Zhen-Ran, Zhu Xiao-Yi, Lu Wei, Sun Wei-Hua, Cheng Ruo-Qian, Ni Jin-Wen, Xi Li, Hussain Khalid, Luo Fei-Hong, Zhang Miao-Ying. Altered Serum Amino Acid and Acylcarnitine Pro files in Hyperinsulinemic Hypoglycemia and Ketotic Hypoglycemia, Frontiers in Endocrinology, 2020 , 11: 0-577373
5)    章淼滢,周怡瑤,陳婕妤,倪錦文,奚立,李曉靜,程若倩,華海梅,羅飛宏, 蛋白敏感性低血糖5例病例報道(dào)及文獻複習, 中華内分泌代謝雜志，2019，35（1）：7-14
6)    Ren Zhengnan, Li Hongli, Zhang Miaoying, Zhao Yali, Fang Xin, Li Xiu, Chen Wei, Zhang Hao, Wang Yang, Pan Lilong, Sun Jia. A Novel Derivative of the Natural Product Danshensu Suppresses Inflammatory Responses to Alleviate Caerulein-Induced Acute Pancreatitis. Front Immunol. 2018 Oct 30;9:2513
7)    章淼滢,葛璟潔,裴舟,董巋然,陳蓮,王炫,張政偉,李曉靜,奚立,程若倩,陸國(guó)平,管一晖,羅飛宏，國(guó)産18F-多巴正電子發(fā)射斷層掃描/CT診斷高胰島素血症性低血糖患兒胰腺不同病竈類型的可行性分析，中華兒科雜志，2017，55（10）：785-789
8)    Zhang, Miaoying ，Chen, Xiuli，Shen, Shuixian，Li, Tang，Chen, Linqi，Hu, Min，Cao, Lingfeng，Cheng, Ruoqian，Zhao, Zhuhui，Luo, Feihong，Sulfonylurea in the treatment of neonatal diabetes mellitus children with heterogeneous genetic backgrounds，Journal of Pediatric Endocrinology & Metabolism，2015，28（7-8）：877-884
9)    Zhang, Miaoying，Guo, Fengxia，Tu, Yuezhen，Kiess, Wieland，Sun, Chengjun，Li, Xi，Lu, Wei，Luo, Feihong，Further increase of obesity prevalence in Chinese children and adolescents - cross-sectional data of two consecutive samples from the city of Shanghai from 2003 to 2008，Pediatric Diabetes，2012，13（7）：572-577
10)    1)Xu Zhenran, Zhang Miaoying, Ni Jinwen, Cheng Ruoqian, Zheng Zhangqian, Xi Li, Luo Feihong. Clinical characteristics and beta-cell function of Chinese children and adolescents with type 2 diabetes from 2009 to 2018. World J Pediatr. 2019 Aug;15(4):405-411
11)    2)Ni Jinwen, Ge Jingjie, Zhang Miaoying, Hussain Khalid, Guan Yihui, Cheng Ruoqian, Xi Li, Zheng Zhangqian, Ren Shuhua, Luo Feihong. Genotype and phenotype analysis of a cohort of patients with congenital hyperinsulinism based on DOPA-PET CT scanning. Eur J Pediatr. 2019 Aug;178(8):1161-1169
12)    3)Yang Lin, Xu Dandan, Sun Chengjun, Wu Jing, Wei Haiyan, Liu Yu, Zhang Miaoying, Luo Feihong. IGF1R Variants in Patients With Growth Impairment: Four Novel Variants and Genotype-Phenotype Correlations. J Clin Endocrinol Metab. 2018;103(11):3939-3944. doi:10.1210/jc.2017-02782
13)    4)李秋月,楊琳,吳靜,陸炜,章淼滢,羅飛宏，ANKRD11基因突變所緻KBG綜合征1例并文獻複習，中國(guó)循證兒科雜志，2018，13（6）：452-458
14)    5)Xu Dandan, Sun Chengjun, Zhou Zhou, Wu Binging, Yang Lin, Chang Zhuo, Zhang Miaoying, Xi Li, Cheng Ruoqian, Ni Jinwen, Luo Feihong. Novel aggrecan variant, p. Gln2364Pro, causes severe familial nonsyndromic adult short stature and poor growth hormone response in Chinese children. BMC Med Genet. 2018 May 16;19(1):79.
15)    6)Sun Chengjun, Pei Zhou, Zhang Miaoying, Sun Bijun, Yang Lin, Zhao Zhuhui, Cheng Ruoqian, Luo Feihong. Recovered insulin production after thiamine administration in permanent neonatal diabetes mellitus with a novel solute carrier family 19 member 2 (SLC19A2) mutation. J Diabetes. 2018 Jan;10(1):50-58
16)    7)鄭章乾,吳冰冰,章淼滢,陸炜,羅飛宏，反複納差伴皮膚色素沉著(zhe)2月餘，中國(guó)當代兒科雜志，2017，19(8): 926-929
17)    8)Sun Chengjun, Wei Haiyan, Chen Xiuli, Zhao Zhuhui, Du Hongwei, Song Wenhui, Yang Yu, Zhang Miaoying, Lu Wei, Pei Zhou, Xi Li, Yan Jian, Zhi Dijing, Cheng Ruoqian, Luo Feihong. ERBB3-rs2292239 as primary type 1 diabetes association locus among non-HLA genes in Chinese. Meta Gene. 2016 May 12;9:120-123
18)    9)常卓,羅飛宏,奚立,程若倩,章淼滢,李曉靜，唐氏綜合征合并橋本毒症、反複腦梗死1例并文獻複習，中國(guó)循證兒科雜志，2015，10（3）：210-215
19)    10)Zhao, Zhuhui，Sun, Chengjun，Wang, Chunfang，Li, Pin，Wang, Wei，Ye, Jun，Gu, Xuefan，Wang, Xiaodong，Shen, Shuixian，Zhi, Dijing，Lu, Zhong，Ye, Rong，Cheng, Ruoqian，Xi, Li，Li, Xiaojing，Zheng, Zhangqian，Zhang, Miaoying， Luo, Feihong(*)，Rapidly rising incidence of childhood type 1 diabetes in Chinese population: epidemiology in Shanghai during 1997-2011，Acta Diabetologica，2014，51（6）：947-953
20)    11)Pei, Zhou，Chen, Xiuli，Sun, Chengjun，Du, Hongwei，Wei, Haiyan，Song, Wenhui，Yang, Yu，Zhang, Miaoying，Lu, Wei，Cheng, Ruoqian，Luo, Feihong(*)，A novel single nucleotide polymorphism in the protein tyrosine phosphatase N22 gene (PTPN22) is associated with Type 1 diabetes in a Chinese population，Diabetic Medicine，2014，31（2）：219-226
21)    12)李曉靜,羅飛宏,裴舟,奚立,葉蓉,趙諸慧,陸炜,章淼滢,鄭章乾，1496例矮小症病因分析及基于IGF-1水平生長(cháng)激素缺乏症診斷預測模型的建立，臨床兒科雜志，2012，30（12）：1110-1115
22)    13)裴舟,李曉靜,王健民,楊毅,高玲玲,沈水仙,支滌靜,陸炜,陸忠,程若倩,奚立,葉蓉,趙諸慧,鄭章乾,章淼滢,羅飛宏，GDF5基因rs224331多态性與漢族青少年體格發(fā)育指标關聯分析，中國(guó)循證兒科雜志，2012，7（4）：274-277
23)    陳秀麗,沈水仙,羅飛宏,章淼滢,李堂,陳臨琪,胡敏,杜虹,曹淩峰,程若倩,趙諸慧,支滌靜，新生兒糖尿病緻病基因分析及其對(duì)療效的影響，中華内分泌代謝雜志，2011，27（6）:488-491
學(xué)術任職：
中國(guó)兒童青少年糖尿病防治專家委員會(huì) 秘書
優生優育協會(huì)兒童生長(cháng)與特殊食品學(xué)組委員
上海市醫師協會(huì)會(huì)員
所獲榮譽：
2023年中國(guó)臨床案例成(chéng)果征集優秀案例
2021年全國(guó)兒科内分泌中青年醫師英語病例演講大賽 二等獎
2018年中華醫學(xué)會(huì)兒科學(xué)分會(huì)内分泌遺傳代謝學(xué)組規範化診治病例比賽 一等獎

2023年06月更新